NATR - NASDAQ

Nature's Sunshine Products, Inc.

NATR·NASDAQ

$19.90

-4.5%

Consumer DefensivePackaged Foods

Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$349.94M

EPS1.0800

P/E Ratio18.43

Earnings Date07/30/2026

261.15M

Assets

3Y+14.0%

5Y+5.0%

10Y+27.0%

99.59M

Total Liabilities

25%

3Y+20.0%

5Y+8.0%

10Y+36.0%

161.55M

Total Equity

3Y+10.0%

5Y+3.0%

10Y+22.0%

Nature's Sunshine Products, Inc. Funding & Solvency Profile

NATR · NASDAQ

Current Assets

Cash & Cash Equivalents93.89M

Net Receivables8.60M

Inventory68.31M

Other Current Assets8.04M

Total Current Assets179 M

Non-Current Assets

Property, Plant & Equipment50.52M

Goodwill & Intangible Assets0.00

Long-Term Investments1.13M

Other Non-Current Assets10.59M

Total Non-Current Assets62 M

Total Assets

261.15M

Financial Health Analysis

Current Ratio

2.28x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.62x

Balanced capital structure with moderate leverage. Equity exceeds debt, suggesting healthy financial stability.

Working Capital

100 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

68% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Nature's Sunshine Products, Inc. Balance Sheet

NATR • NASDAQ

Nature's Sunshine Products, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	93.9M	84.7M	82.4M	60M	86.2M	92.1M	53.6M	50.6M	42.9M	32.3M	41.4M	58.7M	77.2M	79.2M	59M	47.6M	35.5M	34.9M	45.3M	39.1M
Short-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8M	1.8M	2.5M	2M	2.1M	5.7M	6.5M	3.2M	3.9M	4.8M	6.1M
Cash & Short-Term Investments	93.9M	84.7M	82.4M	60M	86.2M	92.1M	53.6M	50.6M	42.9M	34.1M	43.2M	61.2M	79.3M	81.3M	64.6M	54.1M	38.7M	38.7M	50.1M	45.1M
Net Receivables	8.6M	9.5M	8.8M	14.1M	8.9M	7.4M	7.3M	7.8M	8.9M	7.7M	7.7M	6.7M	10.2M	9.6M	9.9M	5.9M	8.3M	10.8M	7.5M	6.4M
Accounts Receivables	8.6M	9.5M	8.8M	14.1M	8.9M	7.4M	7.3M	7.8M	8.9M	7.7M	7.7M	6.7M	10.2M	9.6M	9.9M	5.9M	8.3M	10.8M	7.5M	6.4M
Inventory	68.3M	59.4M	66.9M	67.9M	60.9M	47.7M	46.7M	42M	44M	47.6M	38.5M	40.4M	41.9M	43.3M	41.6M	36.2M	40.6M	39.6M	35.2M	38.6M
Prepaids	0.0	0.0	0.0	0.0	8.8M	6.9M	5.1M	6.4M	5.7M	4.6M	7.1M	7.9M	11.5M	5.8M	4.6M	5.7M	5.6M	7.9M	8.2M	6M
Other Current Assets	8M	7M	7.7M	7.4M	0.0	0.0	0.0	0.0	998K	521K	5M	5M	5.7M	5.3M	4.4M	4.6M	8.1M	11.1M	8.1M	5.7M
Total Current Assets	178.8M	160.6M	165.8M	149.5M	164.7M	154.1M	112.7M	106.8M	102.5M	100.1M	101.5M	121.2M	148.6M	145.3M	125.1M	106.5M	101.4M	108.1M	109M	101.9M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	50.5M	52.4M	58.4M	62.3M	69.2M	74.6M	83.5M	64.1M	69.1M	73.3M	68.7M	51.3M	32M	28M	25.1M	27.4M	28.8M	30.2M	28.3M	30.6M
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	567K	618K	709K	976K	559K	704K	853K	1M	1.2M	1.3M	1.4M	1.5M	1.7M	755K
Goodwill & Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	567K	618K	709K	976K	559K	704K	853K	1M	1.2M	1.3M	1.4M	1.5M	1.7M	755K
Long-Term Investments	1.1M	0.0	0.0	0.0	0.0	0.0	1.2M	1.3M	2M	1.4M	1M	1M	971K	1.3M	1.4M	1.8M	1.8M	1.4M	1.7M	1.6M
Tax Assets	20.1M	17.6M	15.1M	6.9M	13.6M	8.7M	4.9M	9.1M	8.3M	16M	17.3M	14.5M	9.9M	11.5M	16.6M	12.9M	12.2M	6.4M	5.8M	5.7M
Other Non-Current Assets	10.6M	10.2M	10.5M	11.1M	11.4M	12.2M	10.3M	11.1M	12.6M	13.8M	11.3M	8M	7.2M	6.8M	6.4M	9.5M	19.3M	16.6M	18.9M	7.7M
Total Non-Current Assets	82.3M	80.3M	84M	80.3M	94.2M	95.4M	100.4M	86.2M	92.7M	105.4M	99M	75.6M	51M	48.6M	50.7M	52.9M	63.5M	56.2M	56.4M	46.4M
Total Assets	261.1M	240.9M	249.8M	229.8M	258.9M	249.5M	213.1M	193M	195.2M	205.6M	200.5M	196.8M	199.6M	193.9M	175.8M	159.4M	164.9M	164.3M	165.3M	148.3M
LIABILITIES
CURRENT LIABILITIES
Total Payables	12.7M	15.4M	17.7M	13.2M	15.5M	12.1M	5.8M	8.6M	6M	8.8M	8.6M	7.4M	8M	8.3M	14.6M	8.6M	11.7M	11.5M	11.5M	14.1M
Accounts Payable	8M	8.9M	7.9M	6.3M	9.7M	6.5M	4.4M	5.2M	4.2M	5.3M	6.3M	5.2M	5.7M	6.2M	6M	4.9M	4.2M	8.8M	7M	6.5M
Other Payables	4.7M	6.4M	9.8M	6.9M	5.8M	5.6M	1.4M	3.4M	1.8M	3.5M	2.3M	2.1M	2.4M	2.1M	8.7M	3.7M	7.5M	2.7M	4.5M	7.6M
Accrued Expenses	0.0	32.5M	35.7M	36.9M	36.5M	32.6M	30.2M	36.5M	29.1M	26.9M	24.6M	30.3M	31M	26.3M	6.6M	53.2M	51.6M	61.2M	60.2M	59.1M
Short Term Debt	3.3M	0.0	0.0	1.2M	1.5M	2.5M	1.5M	1.5M	506K	9.9M	2.7M	0.0	2.3M	3.4M	3.3M	0.0	0.0	0.0	0.0	0.0
Capital Lease Obligations (Current)	0.0	3.9M	4.5M	4.3M	4.4M	5M	4.9M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	4.7M	6.4M	9.8M	6.9M	5.8M	5.6M	1.4M	3.4M	5.2M	3.5M	4.5M	2.1M	6.9M	5.8M	8.7M	3.7M	7.5M	2.7M	4.5M	7.6M
Deferred Revenue	5.8M	2.8M	1.8M	2.3M	3.7M	2.1M	1.3M	1.2M	3.3M	3.7M	4.2M	4.7M	4.2M	4.3M	2.6M	3.4M	4.5M	5.2M	5.2M	4.8M
Other Current Liabilities	56.7M	11.2M	17.1M	7.8M	15M	15.3M	14.3M	18.9M	14.7M	13.7M	13M	15.5M	23.1M	19.1M	43.3M	3.4M	0.0	0.0	0.0	0.0
Total Current Liabilities	78.5M	65.7M	76.8M	65.6M	76.7M	69.7M	57.9M	66.7M	53.7M	63M	53.1M	57.9M	68.6M	61.4M	67.8M	65.2M	67.9M	77.9M	77M	78M
NON-CURRENT LIABILITIES
Long Term Debt	0.0	0.0	0.0	0.0	1.2M	2.4M	0.0	0.0	13.2M	0.0	0.0	0.0	10M	2.3M	5.9M	0.0	0.0	0.0	0.0	0.0
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	2.6M	0.0	6.6M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	954K	1M	1.4M	1.4M	1.6M	1.4M	1.7M	1.6M	770K	8K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	4.5M	2.9M	1.7M	2M	2.1M	2.4M	3.8M	4.2M	7.9M	10.1M	11.1M	9.9M	15.8M	14.6M	14.7M	25.9M	39.9M	32.7M	28M	2.2M
Total Non-Current Liabilities	21.1M	14.2M	13.5M	17.1M	20.8M	22.6M	25.7M	5.8M	21.8M	10.1M	11.1M	9.9M	25.8M	16.9M	20.6M	25.9M	39.9M	32.7M	28M	2.2M
Capital Lease Obligations	15.6M	14.2M	14.9M	18M	20.3M	21.4M	25.2M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	99.6M	79.9M	90.2M	82.7M	97.5M	92.3M	83.6M	72.4M	75.5M	73.2M	64.3M	67.8M	94.4M	78.3M	88.4M	91M	107.8M	110.6M	104.9M	80.2M
SHAREHOLDERS' EQUITY
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6M	0.0	0.0	0.0	0.0	0.0	0.0
Common Stock	102.2M	114.6M	119.7M	121.6M	133.4M	139.3M	135.7M	133.7M	131.5M	129.7M	126.7M	125.5M	83.1M	77.3M	71.6M	67.8M	67.2M	66.7M	66.6M	64.8M
Additional Paid-In Capital	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	126.7M	125.5M	0.0	77.3M	71.6M	67.8M	67.2M	66.7M	66.6M	0.0
Retained Earnings	76.9M	57.4M	49.7M	34.6M	35M	26M	4.7M	-2.1M	-2.1M	12.7M	18.1M	10.9M	36.1M	48.9M	25.9M	8.3M	9.5M	4.2M	9.1M	20.5M
Accumulated Other Comprehensive Income/Loss	-17.6M	-16.7M	-15.3M	-13.3M	-10.2M	-10M	-11.2M	-11.1M	-10.1M	-11.3M	-11.2M	-11.2M	-14M	-10.6M	-10.1M	-7.6M	-19.6M	-17.2M	-15.3M	-17.1M
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-126.7M	-125.5M	0.0	-77.3M	-71.6M	0.0	-67.2M	-66.7M	-66.6M	0.0
Total Stockholders' Equity	161.6M	155.3M	154.1M	142.9M	158.2M	155.4M	129.2M	120.5M	119.3M	131.1M	133.5M	125.2M	105.3M	115.6M	87.4M	68.4M	57.1M	53.7M	60.4M	68.2M
Total Equity	161.6M	161M	159.5M	147M	161.4M	157.2M	129.4M	120.6M	119.7M	132.4M	136.3M	129M	105.3M	115.6M	87.4M	68.4M	57.1M	53.7M	60.4M	68.2M
Minority Interest	0.0	5.7M	5.5M	4.1M	3.2M	1.8M	227K	63K	411K	1.3M	2.8M	3.8M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SUMMARY
Total Liabilities & Equity	261.1M	240.9M	249.8M	229.8M	258.9M	249.5M	213.1M	193M	195.2M	205.6M	200.5M	196.8M	199.6M	193.9M	175.8M	159.4M	164.9M	164.3M	165.3M	148.3M
Total Investments	1.1M	0.0	0.0	0.0	0.0	0.0	1.2M	1.3M	2M	3.2M	2.8M	3.6M	3M	3.3M	7.1M	8.2M	4.9M	5.3M	6.4M	7.6M
Total Debt	18.9M	14.2M	14.9M	19.2M	23M	26.3M	26.7M	1.5M	13.7M	9.9M	2.7M	0.0	12.3M	5.6M	9.2M	0.0	0.0	0.0	0.0	0.0
Net Debt	-75M	-70.5M	-67.5M	-40.8M	-63.2M	-65.7M	-27M	-49.1M	-29.2M	-22.4M	-38.7M	-58.7M	-65M	-73.6M	-49.8M	-47.6M	-35.5M	-34.9M	-45.3M	-39.1M
Shares Outstanding	17,635,552	17,635,552	17,635,552	17,635,552	17,635,552	17,635,552	17,635,552	17,635,552	17,635,552	17,635,552	17,635,552	17,635,552	17,635,552	17,635,552	17,635,552	17,635,552	17,635,552	17,635,552	17,635,552	17,635,552

SEC Filings

NATR - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 11, 2026	May 11, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 07, 2026	May 07, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 07, 2026	March 31, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	March 27, 2026	March 27, 2026	2026	View Filing
10-K 10-K 2025 FY FY	March 10, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	March 10, 2026	March 10, 2026	2026	View Filing
10-Q 10-Q 2025 Q3 Q3	November 06, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 06, 2025	November 06, 2025	2025	View Filing
8-K 8-K 2025 N/A	October 15, 2025	October 10, 2025	2025	View Filing
8-K 8-K 2025 N/A	July 31, 2025	July 31, 2025	2025	View Filing

Showing 1 to 10 of 362 filings

Related Guides

Blog Categories

Continue your NATR research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.